Windtree Therapeutics (WINT) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free WINT Stock Alerts $4.49 +0.19 (+4.42%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Windtree Therapeutics Short Interest DataCurrent Short Volume12,700 sharesPrevious Short Volume2,600 sharesChange Vs. Previous Month+388.46%Dollar Volume Sold Short$63,881.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares590,000 sharesFloat Size424,400 sharesShort Percent of Float2.99%Today's Trading Volume8,000 sharesAverage Trading Volume24,208 sharesToday's Volume Vs. Average33% Short Selling Windtree Therapeutics ? Sign up to receive the latest short interest report for Windtree Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatWINT Short Interest Over TimeWINT Days to Cover Over TimeWINT Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Windtree Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202412,700 shares $63,881.00 +388.5%3.0%0.6 $5.03 4/15/20242,600 shares $19,656.00 -93.5%N/A0.2 $7.56 3/31/202439,700 shares $14,053.80 +30.2%0.5%0.2 $0.35 3/15/202430,500 shares $10,370.00 -47.8%0.4%0.1 $0.34 2/29/202458,400 shares $21,024.00 -42.2%0.8%0.2 $0.36 2/15/2024101,100 shares $36,092.70 -56.0%1.9%0.3 $0.36 Get the Latest News and Ratings for WINT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Windtree Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024229,600 shares $96,500.88 +353.8%5.3%0.8 $0.42 1/15/202450,600 shares $28,953.32 +25.6%1.0%0.2 $0.57 12/31/202340,300 shares $28,975.70 +108.8%N/A0.3 $0.72 12/15/202319,300 shares $14,089.00 -55.5%0.5%0.2 $0.73 11/30/202343,400 shares $50,344.00 -13.4%1.1%0.4 $1.16 11/15/202350,100 shares $46,081.98 -22.5%1.2%0.5 $0.92 10/31/202364,600 shares $67,830.00 -65.8%1.5%0.5 $1.05 10/15/2023188,900 shares $236,125.00 +540.3%4.3%1.5 $1.25 9/30/202329,500 shares $27,983.70 +81.0%0.7%0.2 $0.95 9/15/202316,300 shares $18,745.00 +27.3%0.4%0.1 $1.15 8/31/202312,800 shares $14,095.36 -75.8%2.0%0.1 $1.10 8/15/202352,800 shares $85,536.00 +294.0%7.9%0.2 $1.62 7/31/202313,400 shares $18,626.00 +162.8%2.0%0 $1.39 7/15/20235,100 shares $6,834.00 -42.1%N/A0 $1.34 6/30/20238,800 shares $11,000.00 -90.5%N/A0 $1.25 6/15/202392,500 shares $142,450.00 -2.9%N/A0.1 $1.54 5/31/202395,300 shares $121,984.00 -51.2%N/A0.1 $1.28 5/15/2023195,100 shares $290,699.00 +64.4%N/A0.2 $1.49 4/30/2023118,700 shares $194,668.00 +136.9%68.7%0.1 $1.64 4/15/202350,100 shares $219,438.00 +87.6%8.5%0.1 $4.38 3/31/202326,700 shares $133,233.00 -2.9%4.7%0.2 $4.99 3/15/202327,500 shares $132,550.00 -53.0%4.9%0.3 $4.82 2/28/202358,500 shares $367,380.00 +604.8%10.3%0.6 $6.28 2/15/20238,300 shares $1,232.55 -98.9%N/A0.1 $0.15 1/31/2023754,800 shares $120,768.00 +16.1%N/A1.4 $0.16 1/15/2023650,300 shares $143,033.49 -28.2%N/A1.3 $0.22 12/30/2022905,900 shares $154,003.00 -28.7%N/A2 $0.17 12/15/20221,270,000 shares $226,060.00 +4.1%N/A1.4 $0.18 11/30/20221,220,000 shares $234,850.00 -3.2%N/A1.3 $0.19 11/15/20221,260,000 shares $110,250.00 -9.4%5.3%1.2 $0.09 10/31/20221,390,000 shares $238,385.00 -10.9%7.4%0.7 $0.17 10/15/20221,560,000 shares $379,704.00 +26.8%8.3%0.8 $0.24 9/30/20221,230,000 shares $369,123.00 +44.6%6.5%0.7 $0.30 9/15/2022850,900 shares $314,662.82 -8.3%4.5%0.6 $0.37Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit WINT Short Interest - Frequently Asked Questions What is Windtree Therapeutics' current short interest? Short interest is the volume of Windtree Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 12,700 shares of WINT short. 2.99% of Windtree Therapeutics' shares are currently sold short. Learn More on Windtree Therapeutics' current short interest. What is a good short interest ratio for Windtree Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WINT shares currently have a short interest ratio of 1.0. Learn More on Windtree Therapeutics's short interest ratio. What is a good short interest percentage for Windtree Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.99% of Windtree Therapeutics' floating shares are currently sold short. Is Windtree Therapeutics' short interest increasing or decreasing? Windtree Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 12,700 shares, an increase of 388.5% from the previous total of 2,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Windtree Therapeutics' float size? Windtree Therapeutics currently has issued a total of 590,000 shares. Some of Windtree Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Windtree Therapeutics currently has a public float of 424,400 shares. How does Windtree Therapeutics' short interest compare to its competitors? 2.99% of Windtree Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Windtree Therapeutics: Avalon GloboCare Corp. (1.02%), Finch Therapeutics Group, Inc. (4.88%), Scinai Immunotherapeutics Ltd. (0.47%), Acorda Therapeutics, Inc. (0.66%), TC Biopharm (Holdings) Plc (5.87%), TRACON Pharmaceuticals, Inc. (7.29%), Fresh Tracks Therapeutics, Inc. (0.17%), Palisade Bio, Inc. (21.34%), Titan Pharmaceuticals, Inc. (1.99%), Creative Medical Technology Holdings, Inc. (1.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Windtree Therapeutics stock? Short selling WINT is an investing strategy that aims to generate trading profit from Windtree Therapeutics as its price is falling. WINT shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Windtree Therapeutics? A short squeeze for Windtree Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WINT, which in turn drives the price of the stock up even further. How often is Windtree Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WINT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ALBT Short Interest FNCH Short Interest SCNI Short Interest ACOR Short Interest TCBP Short Interest TCON Short Interest FRTX Short Interest PALI Short Interest TTNP Short Interest CELZ Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:WINT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders